CareCloud Price Target Maintained With a $4.50/Share by Benchmark
CareCloud Analyst Ratings
Benchmark Co. Maintains CareCloud(CCLD.US) With Buy Rating, Maintains Target Price $4.5
Maxim Group Maintains CareCloud(CCLD.US) With Buy Rating, Maintains Target Price $6
CareCloud's Strategic Growth and Financial Stability Justify Buy Rating
Roth MKM Downgrades CareCloud(CCLD.US) to Hold Rating, Cuts Target Price to $3.5
Maxim Group Maintains CareCloud(CCLD.US) With Buy Rating, Announces Target Price $6
CareCloud Price Target Raised to $4.50/Share From $4.00 by Benchmark
CareCloud Analyst Ratings
Benchmark Co. Maintains CareCloud(CCLD.US) With Buy Rating, Raises Target Price to $4.5
CareCloud (CCLD) Receives a Buy From Benchmark Co.
Maxim Group Maintains CareCloud(CCLD.US) With Buy Rating
Roth MKM Maintains CareCloud(CCLD.US) With Buy Rating, Maintains Target Price $5
Benchmark: Maintaining the CareCloud (CCLD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $3.50 to $4.00.
CareCloud Analyst Ratings
Benchmark Maintains Buy on CareCloud, Raises Price Target to $4
Analysts Offer Insights on Healthcare Companies: CARGO Therapeutics, Inc. (CRGX), Helius Medical Technologies (HSDT) and CareCloud (CCLD)
CareCloud Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: CareCloud (CCLD), AbSci (ABSI)
CareCloud Analyst Ratings